BCG and BCG/DNAhsp65 vaccinations promote protective effects without deleterious consequences for experimental autoimmune encephalomyelitis

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Zorzella Pezavento, Sofia Fernanda Gonçalves ^a   Guerino, Clara Pires Fujiara ^a   Chiuso Minicucci, Fernanda ^a   França, Thais Graziela Donegá ^a   Ishikawa, Larissa Lumi Watanabe ^a   Masson, Ana Paula ^b   Silva, Célio Lopes ^b   Sartori, Alexandrina ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; DNA VACCINE; GAMMA INTERFERON; INTERLEUKIN 10; MYELIN BASIC PROTEIN; PVAXHSP65 VACCINE; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BCG VACCINATION; CELL INFILTRATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA IMMUNIZATION; FEMALE; IMMUNE RESPONSE; INFLAMMATORY INFILTRATE; NONHUMAN; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; WEIGHT REDUCTION; ANIMAL; BIOSYNTHESIS; BOVINE TUBERCULOSIS; BRAIN; CATTLE; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; IMMUNOLOGY; METABOLISM; MYCOBACTERIUM BOVIS; PATHOLOGY; SPINAL CORD;

ANIMALS; BCG VACCINE; BRAIN; CATTLE; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; INTERFERON-GAMMA; INTERLEUKIN-10; MYCOBACTERIUM BOVIS; RATS; SPINAL CORD; TUBERCULOSIS, BOVINE;

EID: 84888870137     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/721383     Document Type: Article

References (54)

1. Young D. B., Duncan K., Prospects for new interventions in the treatment and prevention of mycobacterial disease. Annual Review of Microbiology 1995 49 641 673 2-s2.0-0028879494
2. Flynn J. L., Chan J., Tuberculosis: latency and reactivation. Infection and Immunity 2001 69 7 4195 4201 2-s2.0-0034977241 10.1128/IAI.69.7.4195-4201. 2001 (Pubitemid 32574413)
3. Dierberg K. L., Chaisson R. E., Human immunodeficiency virus-associated tuberculosis: update on prevention and treatment. Clinics in Chest Medicine 2013 34 2 217 228
4. Pontali E., Matteelli A., Migliori G. B., Drug-resistant tuberculosis. Current Opinion in Pulmary Medicine 2013 19 3 266 272
5. Andersen P., Doherty T. M., The success and failure of BCG-implications for a novel tuberculosis vaccine. Nature Reviews Microbiology 2005 3 8 656 662 2-s2.0-22944433876 10.1038/nrmicro1211 (Pubitemid 41052152)
6. Centers for Disease Control and Prevention, Global routine vaccination coverage, 2011. MMWR Morbidity and Mortality Weekly Report 2012 61 43 883 885
7. Colditz G. A., Brewer T. F., Berkey C. S., Wilson M. E., Burdick E., Fineberg H. V., Mosteller F., Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature. Journal of the American Medical Association 1994 271 9 698 702 2-s2.0-0028153628 10.1001/jama.271.9.698 (Pubitemid 24061706)
8. Springett V. H., Sutherland I., A re-examination of the variations in the efficacy of BCG vaccination against tuberculosis in clinical trials. Tubercle and Lung Disease 1994 75 3 227 133 2-s2.0-0027966864 10.1016/0962-8479(94)90013- 2
9. Behr M. A., Wilson M. A., Gill W. P., Salamon H., Schoolnik G. K., Rane S., Small P. M., Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 1999 284 5419 1520 1523 2-s2.0-0033612136 10.1126/science.284.5419.1520 (Pubitemid 29291397)
10. Fine P. E. M., Variation in protection by BCG: implications of and for heterologous immunity. The Lancet 1995 346 8986 1339 1345 2-s2.0-0028872014
11. Skeiky Y. A. W., Sadoff J. C., Advances in tuberculosis vaccine strategies. Nature Reviews Microbiology 2006 4 6 469 476 2-s2.0-33646822975 10.1038/nrmicro1419 (Pubitemid 43771866)
12. Orme I. M., Beyond BCG: the potential for a more effective TB vaccine. Molecular Medicine Today 1999 5 11 487 492 2-s2.0-0033231909 10.1016/S1357-4310(99)01594-4 (Pubitemid 29491449)
13. McMurray D. N., A coordinated strategy for evaluating new vaccines for human and animal tuberculosis. Tuberculosis 2001 81 1-2 141 146 2-s2.0-0034987009 10.1054/tube.2000.0265 (Pubitemid 32500100)
14. Andersen P., TB vaccines: progress and problems. Trends in Immunology 2001 22 3 160 168 2-s2.0-0034913656 10.1016/S1471-4906(01)01865-8 (Pubitemid 32675264)
15. Tascon R. E., Colston M. J., Ragno S., Stavropoulos E., Gregory D., Lowrie D. B., Vaccination against tuberculosis by DNA injection. Nature Medicine 1996 2 8 888 892 2-s2.0-0029796404 10.1038/nm0896-888 (Pubitemid 26296759)
16. Lowrie D. B., Silva C. L., Colston M. J., Ragno S., Tascon R. E., Protection against tuberculosis by a plasmid DNA vaccine. Vaccine 1997 15 8 834 838 2-s2.0-0030743496 10.1016/S0264-410X(97)00073-X (Pubitemid 27287969)
17. Tanghe A., D'Souza S., Rosseels V., Denis O., Ottenhoff T. H. M., Dalemans W., Wheeler C., Huygen K., Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting. Infection and Immunity 2001 69 5 3041 3047 2-s2.0-0035059044 10.1128/IAI.69.5.3041-3047.2001 (Pubitemid 32332198)
18. Bonato V. L. D., Lima V. M. F., Tascon R. E., Lowrie D. B., Silva C. L., Identification and characterization of protective T cells in hsp65 DNA-vaccinated and Mycobacterium tuberculosis -infected mice. Infection and Immunity 1998 66 1 169 175 2-s2.0-0031965025
19. Lowrie D. B., Silva C. L., Tascon R. E., DNA vaccines against tuberculosis. Immunology and Cell Biology 1997 75 6 591 594 2-s2.0-0031409105 (Pubitemid 28103741)
20. + cells, interferon- γ recovery and reduction of lung injury. Immunology 2004 113 1 130 138 2-s2.0-4444271905 10.1111/j.1365-2567.2004.01931.x (Pubitemid 39178852)
21. Pelizon A., Martins D. R., Zorzella S. F. G., Trombone A. P., Lorenzi J. C. C., Carvalho R. F., Brandão I. T., Coelho-Castelo A. A. M., Silva C. L., Sartori A., Genetic vaccine for tuberculosis (pVAXhsp65) primes neonate mice for a strong immune response at the adult stage. Genetic Vaccines and Therapy 2007 5, article 12 2-s2.0-38949193197 10.1186/1479-0556-5-12 (Pubitemid 351217935)
22. de Paula L., Silva C. L., Carlos D., Matias-Peres C., Sorgi C. A., Soares E. G., Souza P. R. M., Bladés C. R. Z., Galleti F. C. S., Bonato V. L. D., Gonçalves E. D. C., Silva É. V. G., Faccioli L. H., Comparison of different delivery systems of DNA vaccination for the induction of protection against tuberculosis in mice and guinea pigs. Genetic Vaccines and Therapy 2007 5, article 2 2-s2.0-33847274667 10.1186/1479-0556-5-2 (Pubitemid 46322123)
23. Gonçalves E. D. C., Bonato V. L., da Fonseca D. M., Soares E. G., Brandão I. T., Soares A. P. M., Silva C. L., Improve protective efficacy of a TB DNA-HSP65 vaccine by BCG priming. Genetic Vaccines and Therapy 2007 5, article 7 2-s2.0-35648991882 10.1186/1479-0556-5-7 (Pubitemid 350020765)
24. Feige U., van Eden W., Infection, autoimmunity and autoimmune disease. EXS 1996 77 359 373 2-s2.0-0029682474
25. Horváth L., Cervenak L., Oroszlán M., Prohászka Z., Uray K., Hudecz F., Baranyi É., Madácsy L., Singh M., Romics L., Füst G., Pánczél P., Antibodies against different epitopes of heat-shock protein 60 in children with type 1 diabetes mellitus. Immunology Letters 2002 80 3 155 162 2-s2.0-0036498093 10.1016/S0165-2478(01)00336-4 (Pubitemid 34136002)
26. Keren P., George J., Shaish A., Levkovitz H., Janakovic Z., Afek A., Goldberg I., Kopolovic J., Keren G., Harats D., Effect of hyperglycemia and hyperlipidemia on atherosclerosis in LDL receptor-deficient mice: establishment of a combined model and association with heat shock protein 65 immunity. Diabetes 2000 49 6 1064 1069 2-s2.0-19244377379 (Pubitemid 30349431)
27. Cohen I. R., Autoimmunity to chaperonins in the pathogenesis of arthritis and diabetes. Annual Review of Immunology 1991 9 567 589 2-s2.0-0025811883
28. Birnbaum G., Stress proteins: their role in the normal central nervous system and in disease states, especially multiple sclerosis. Springer Seminars in Immunopathology 1995 17 1 107 118 2-s2.0-0029035340
29. Tsunoda I., Tolley N. D., Theil D. J., Whitton J. L., Kobayashi H., Fujinami R. S., Exacerbation of viral and autoimmune animal models for multiple sclerosis by bacterial DNA. Brain Pathology 1999 9 3 481 493 2-s2.0-0032976985 (Pubitemid 29316288)
30. Segal B. M., Chang J. T., Shevach E. M., CpG oligonucleotides are potent adjuvants for the activation of autoreactive encephalitogenic T cells in vivo. Journal of Immunology 2000 164 11 5683 5688 2-s2.0-0034043957 (Pubitemid 30389809)
31. Nakamura T., Yamamura J.-I., Sato H., Kakinuma H., Takahashi H., Vasculitis induced by immunization with Bacillus Calmette-Guérin followed by atypical mycobacterium antigen: a new mouse model for Kawasaki disease. FEMS Immunology and Medical Microbiology 2007 49 3 391 397 2-s2.0-33947279513 10.1111/j.1574-695X.2007.00217.x (Pubitemid 46435017)
32. Dubaniewicz A., Mycobacterium tuberculosis heat shock proteins and autoimmunity in sarcoidosis. Autoimmunity Reviews 2010 9 6 419 424 2-s2.0-77949916875 10.1016/j.autrev.2009.11.015
33. Chiuso-Minicucci F., Van D. B., Zorzella-Pezavento S. F. G., Peres R. S., Ishikawa L. L. W., Rosa L. C., França T. G. D., Turato W. M., Amarante A. F. T., Sartori A., Experimental autoimmune encephalomyelitis evolution was not modified by multiple infections with Strongyloides venezuelensis. Parasite Immunology 2011 33 5 303 308 2-s2.0-79953785034 10.1111/j.1365-3024.2011.01279.x
34. Peres R. S., Chiuso-Minicucci F., da Rosa L. C., Previous contact with Strongyloides venezuelensis contributed to prevent insulitis in MLD-STZ diabetes. Experimental Parasitology 2013 134 2 183 189
35. Tischler M., Shoenfeld Y., Tuberculose et immunite: ou en sommes-nous? Annales de L'Institut Pasteur/ActuaLités 1996 7 2 133 136
36. Baxter A. G., Horsfall A. C., Healey D., Ozegbe P., Day S., Williams D. G., Cooke A., Mycobacteria precipitate an SLE-like syndrome in diabetes-prone NOD mice. Immunology 1994 83 2 227 231 2-s2.0-0028139108 (Pubitemid 24315591)
37. Rodrigues L. C., Diwan V. K., Wheeler J. G., Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. International Journal of Epidemiology 1993 22 6 1154 1158 2-s2.0-0027751819 (Pubitemid 24025695)
38. Colditz G. A., Berkey C. S., Mosteller F., Brewer T. F., Wilson M. E., Burdick E., Fineberg H. V., The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics 1995 96 1 I 29 35 2-s2.0-0029068308
39. Sterne J. A. C., Rodrigues L. C., Guedes I. N., Does the efficacy of BCG decline with time since vaccination? International Journal of Tuberculosis and Lung Disease 1998 2 3 200 207 2-s2.0-0031939337 (Pubitemid 28123518)
40. Engelhardt B., Molecular mechanisms involved in T cell migration across the blood-brain barrier. Journal of Neural Transmission 2006 113 4 477 485 2-s2.0-33645087923 10.1007/s00702-005-0409-y
41. van Eden W., Tholet J. E. R., Zee R. V. D., Noordzij A., Van Embden J. D. A., Hensen E. J., Cohen I. R., Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis. Nature 1988 331 6152 171 173 2-s2.0-0024285835 (Pubitemid 18042149)
42. Harada M., Kishimoto Y., Makino S., Prevention of overt diabetes and insulitis in NOD mice by a single BCG vaccination. Diabetes Research and Clinical Practice 1990 8 2 85 89 2-s2.0-0025061142 10.1016/0168-8227(90)90017-N (Pubitemid 20034055)
43. Baik S. H., Park I. B., Choi K. M., Kim Y. H., Kim N. H., Kim S. J., Song G. G., Choi D. S., BCG vaccine prevents insulitis in low dose streptozotocin-induced diabetic mice. Diabetes Research and Clinical Practice 1999 46 2 91 97 2-s2.0-0344069775 10.1016/S0168-8227(99)00079-0 (Pubitemid 29509915)
44. Sewell D. L., Reinke E. K., Co D. O., Hogan L. H., Fritz R. B., Sandor M., Fabry Z., Infection with Mycobacterium bovis BCG diverts traffic of myelin oligodendroglial glycoprotein autoantigen-specific T cells away from the central nervous system and ameliorates experimental autoimmune encephalomyelitis. Clinical and Diagnostic Laboratory Immunology 2003 10 4 564 572 2-s2.0-0038105562 10.1128/CDLI.10.4.564-572.2003 (Pubitemid 36890439)
45. van Eden W., van der Zee R., Prakken B., Heat-shock proteins induce T-cell regulation of chronic inflammation. Nature Reviews Immunology 2005 5 4 318 330 2-s2.0-17144417382 10.1038/nri1593 (Pubitemid 40516157)
46. van Eden W., Wick G., Albani S., Cohen I., Stress, heat shock proteins, and autoimmunity: how immune responses to heat shock proteins are to be used for the control of chronic inflammatory diseases. Annals of the New York Academy of Sciences 2007 1113 217 237 2-s2.0-35548988445 10.1196/annals.1391.020 (Pubitemid 350015017)
47. Santos R. R. Jr., Sartori A., De Franco M., Filho O. G. R., Coelho-Castelo A. A. M., Bonato V. L. D., Cabrera W. H. K., Ibañez O. M., Silva C. L., Immunomodulation and protection induced by DNA-hsp65 vaccination in an animal model of arthritis. Human Gene Therapy 2005 16 11 1338 1345 2-s2.0-27744486100 10.1089/hum.2005.16.1338 (Pubitemid 41611662)
48. Dos Santos R. R. Jr., Sartori A., Deperon Bonato V. L., Coelho Castelo A. A. M., Vilella C. A., Zollner R. L., Lopes Silva C., Immune modulation induced by tuberculosis DNA vaccine protects non-obese diabetic mice from diabetes progression. Clinical and Experimental Immunology 2007 149 3 570 578 2-s2.0-34547875389 10.1111/j.1365-2249.2007.03433.x (Pubitemid 47256151)
49. Zorzella-Pezavento S. F. G., Chiuso-Minicucci F., França T. G. D., Ishikawa L. L. W., Martins D. R., Silva C. L., Sartori A., Immunization with pVAXhsp65 decreases inflammation and modulates immune response in experimental encephalomyelitis. NeuroImmunoModulation 2010 17 5 287 297 2-s2.0-77950957840 10.1159/000292018
50. da Rosa L. C., Chiuso-Minicucci F., Zorzella-Pezavento S. F. G., BCG/DNAhsp65 prime-boost is protective against diabetes in NOD mice but not in the STZ model of type 1 diabetes. Clinical and Experimental Immunology 2013 173 3 430 437
51. + T cells: a mechanism for suppression of autoimmunity during BCG infection. Journal of Autoimmunity 2005 24 2 93 100 2-s2.0-17044419165 10.1016/j.jaut.2005.01.005
52. Tran E. H., Prince E. N., Owens T., IFN- γ shapes immune invasion of the central nervous system via regulation of chemokines. Journal of Immunology 2000 164 5 2759 2768 2-s2.0-0034162486 (Pubitemid 30115510)
53. Furlan R., Brambilla E., Ruffini F., Poliani P. L., Bergami A., Marconi P. C., Franciotta D. M., Penna G., Comi G., Adorini L., Martino G., Intrathecal delivery of IFN- γ protects C57BL/6 mice from chronic-progressive experimental autoimmune encephalomyelitis by increasing apoptosis of central nervous system-infiltrating lymphocytes. Journal of Immunology 2001 167 3 1821 1829 2-s2.0-0035423415 (Pubitemid 32703187)
54. Jadidi-Niaragh F., Mirshafiey A., Regulatory T-cell as orchestra leader in immunosuppression process of multiple sclerosis. Immunopharmacology and Immunotoxicology 2011 33 3 545 567 2-s2.0-79961140179 10.3109/08923973.2010. 513391